<?xml version="1.0"?>
<body status="ats"><p nid="t0:ats:1">SRES 57 ATS</p><p/><center><p nid="t0:ats:2">113th CONGRESS</p></center>
<p/><center><p nid="t0:ats:3">1st Session</p></center>
<p/><center><p nid="t0:ats:4">S. RES. 57</p></center>
<p nid="t0:ats:5">Designating February 28, 2013, as &#x2018;Rare Disease Day&#x2019;.</p><p/><center><p nid="t0:ats:6">IN THE SENATE OF THE UNITED STATES</p></center>
<p/><h3 nid="t0:ats:7"><center><p nid="t0:ats:8">February 26, 2013</p></center></h3>
<p nid="t0:ats:9">Mr. BROWN (for himself, Mr. BARRASSO, Mr. WHITEHOUSE, Mr. PRYOR, and Mrs. HAGAN) submitted the following resolution; which was considered and agreed to</p><hr/><p/><center><p nid="t0:ats:10">RESOLUTION</p></center>
<p nid="t0:ats:11">Designating February 28, 2013, as &#x2018;Rare Disease Day&#x2019;.</p><p nid="t0:ats:12">Whereas rare diseases and disorders are those that affect a small number of patients, typically less than 200,000 people in the United States;</p><p nid="t0:ats:13">Whereas, as of the date of approval of this resolution, nearly 7,000 rare diseases affect approximately 30,000,000 people in the United States and their families;</p><p nid="t0:ats:14">Whereas children with rare genetic diseases account for more than half of the population affected by rare diseases in the United States;</p><p nid="t0:ats:15">Whereas many rare diseases are serious, life-threatening, and lack an effective treatment;</p><p nid="t0:ats:16">Whereas rare diseases and conditions include epidermolysis bullosa, progeria, sickle cell anemia, Tay-Sachs, cystic fibrosis, many childhood cancers, and fibrodysplasia ossificans progressiva;</p><p nid="t0:ats:17">Whereas people with rare diseases experience challenges that include difficulty in obtaining an accurate diagnosis, limited treatment options, and difficulty finding physicians or treatment centers with expertise in their diseases;</p><p nid="t0:ats:18">Whereas great strides have been made in research and treatment for rare diseases as a result of the Orphan Drug Act (<public-law-reference session="97" number="414">Public Law 97-414</public-law-reference>; 96 Stat. 2049) and amendments made by that Act;</p><p nid="t0:ats:19">Whereas 2013 marks the 30th anniversary of the Orphan Drug Act and therefore a time to reflect upon the successes of that Act and the challenges to be addressed in the future;</p><p nid="t0:ats:20">Whereas both the Food and Drug Administration and the National Institutes of Health have established special offices to advocate for rare disease research and treatments;</p><p nid="t0:ats:21">Whereas the National Organization for Rare Disorders, an organization established in 1983 to provide services to, and advocate on behalf of, patients with rare diseases, was a primary force behind the enactment of the Orphan Drug Act and remains a critical public voice for people with rare diseases;</p><p nid="t0:ats:22">Whereas the National Organization for Rare Disorders sponsors Rare Disease Day in the United States to increase public awareness of rare diseases;</p><p nid="t0:ats:23">Whereas Rare Disease Day has become a global event occurring annually on the last day of February and was observed in more than 60 countries in 2012;</p><p nid="t0:ats:24">Whereas Rare Disease Day was observed in the United States for the first time on February 28, 2009; and</p><p nid="t0:ats:25">Whereas Rare Disease Day is anticipated to be observed globally for years to come, providing hope and information for rare disease patients around the world; Now, therefore, be it</p><ul><p nid="t0:ats:26"><em>  Resolved,</em> That the Senate--</p><ul><p nid="t0:ats:27">(1) designates February 28, 2013, as &#x2018;Rare Disease Day&#x2019;;</p><p nid="t0:ats:28">(2) recognizes the importance of improving awareness and encouraging accurate and early diagnosis of rare diseases and disorders; and</p><p nid="t0:ats:29">(3) supports a national and global commitment to improving access to, and developing new treatments, diagnostics, and cures for, rare diseases and disorders.</p></ul></ul></body>
